Clinical utility of 99mTc-sestamibi scintimammography in the management of equivocal breast lesions

Cancer Biotherapy and Radiopharmaceuticals

Volumn 19, Issue 5, 2004, Pages 621-626

  De Cicco, Concetta ^a   Trifirò, Giuseppe ^a   Baio, Silvia ^a   Sierra, Maribel Lopera ^a   Pizzamiglio, Maria ^a   Cassano, Enrico ^a   Prisco, Gennaro ^a   Gatti, Giovanna ^a   Galimberti, Viviana ^a   Luini, Alberto ^a   Paganelli, Giovanni ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

99mTc sestamibi; Breast neoplasms; Radionuclide imaging; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY ANALYSIS; BREAST TUMOR; LABORATORY DIAGNOSIS; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; RADIOGRAPHY; RECURRENT DISEASE; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 9144265171     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/1084978042484858     Document Type: Article

References (15)

1. Kerlinowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33.
2. Kopans DB. The positive predictive value of mammography. Am J Roentgenol 1992;158:521.
3. Kopans DB. Accuracy of mammographic interpretation. [editorial; comment] New Engl J Med 1994;331:1521.
4. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21: 432.
5. Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626.
6. Khalkhali I, Cutrone I, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med 1995;36: 1784.
7. 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Sem Nucl Med 1999;29:16.
8. Tolmos J, Cutrone JA, Wang B, et al. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer Inst 1998;90:846.
9. Liberman L, Abramson AF, Squires FB, et al. The breast imaging reporting and data system: Positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol 1998;171:35.
10. Palmedo H, Biersack HJ, Lastoria S, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: Results of a prospective European multicenter trial. Eur J Nucl Med 1998;25:375.
11. 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 1999;40:296.
12. Tiling R, Khalkhali I, Sommer H, et al. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Nucl Med Comm 1998;19:55.
13. Buscombe JR, Cwikla JB, Holloway B, et al. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves. J Nucl Med 2001;42:3.
14. Luini A, Zurrida S, Galimberti V, et al. Radioguided surgery of occult breast lesions. Eur J Cancer 1998;34:204.
15. De Cicco C, Pizzamiglio M, Trifiro G, et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med 2002;46:145.